Inventor · disambiguated record
Yong Wang
Also filed as: WANG YONG · WANG YONG-XU
38 granted patents·33 pending applications·596 citations·filing 2004–2025
98Inventor score
Top patents by PatentIndex Score
71 records- 0198US7579473B2c-Met modulators and methods of useEXELIXIS INC·Filed 2009·Granted Aug 25, 2009·95 cites·7 claims
- 0297US8497284B2C-met modulators and method of useBANNEN LYNNE CANNE·Filed 2011·Granted Jul 30, 2013·60 cites·23 claims
- 0397US8067436B2c-Met modulators and methods of useBANNEN LYNNE CANNE·Filed 2007·Granted Nov 29, 2011·59 cites·4 claims
- 0496US9174947B2c-Met modulators and methods of useBANNEN LYNNE CANNE·Filed 2006·Granted Nov 3, 2015·45 cites·6 claims
- 0596US8476298B2c-Met modulators and method of useBANNEN LYNNE CANNE·Filed 2007·Granted Jul 2, 2013·39 cites·11 claims
- 0696US8178532B2c-Met modulators and method of useBANNEN LYNNE CANNE·Filed 2007·Granted May 15, 2012·46 cites·3 claims
- 0796US7989622B2Phosphatidylinositol 3-kinase inhibitors and methods of their useEXELIXIS INC·Filed 2006·Granted Aug 2, 2011·64 cites·7 claims
- 0895US11124482B2C-met modulators and methods of useEXELIXIS INC·Filed 2017·Granted Sep 21, 2021·6 cites·11 claims
- 0995US7977345B2c-MET modulators and method of useEXELIXIS INC·Filed 2005·Granted Jul 12, 2011·48 cites·3 claims
- 1091US7132533B2Tricyclic compounds protein kinase inhibitors for enhancing the efficacy of anti-neoplastic agents and radiation therapyAGOURON PHARMA·Filed 2005·Granted Nov 7, 2006·21 cites·3 claims
- 1190US7462713B2Tricyclic compounds protein kinase inhibitors for enhancing the efficacy of anti-neoplastic agents and radiation therapyAGOURON PHARMA·Filed 2006·Granted Dec 9, 2008·18 cites·9 claims
- 1288US8748412B2Phenylalanine derivatives and their use as non-peptide GLP-1 receptor modulatorsLIAO JIAYU·Filed 2011·Granted Jun 10, 2014·29 cites·54 claims
- 1388US8044062B2Substituted pyrido[2,3-d]pyrimidin-7(8H)-one inhibitors of phospatidylinositol 3-kinase alphaEXELIXIS INC·Filed 2006·Granted Oct 25, 2011·15 cites·37 claims
- 1486US11718622B2Heterocyclic adenosine receptor antagonistsEXELIXIS INC·Filed 2021·Granted Aug 8, 2023·1 cites·27 claims
- 1584US11542259B2Compounds for the treatment of kinase-dependent disordersEXELIXIS INC·Filed 2019·Granted Jan 3, 2023·3 cites·2 claims
- 1683US11708367B2Compounds for the treatment of kinase-dependent disordersEXELIXIS INC·Filed 2019·Granted Jul 25, 2023·2 cites·20 claims
- 1781US6967198B2Tricyclic compounds protein kinase inhibitors for enhancing the efficacy of anti-neoplastic agents and radiation therapyAGOURON PHARMA·Filed 2004·Granted Nov 22, 2005·17 cites·37 claims
- 1879US12371462B2Brown fat-selective adipokinesUNIV MASSACHUSETTS·Filed 2023·Granted Jul 29, 2025·0 cites·5 claims
- 1979US8026237B2Pyrrole derivatives as pharmaceutical agentsEXELIXIS INC·Filed 2005·Granted Sep 27, 2011·4 cites·18 claims
- 2078US8076338B2Kinase modulators and methods of useANAND NEEL K·Filed 2005·Granted Dec 13, 2011·7 cites·53 claims
- 2176US8222263B2Inhibitors of hedgehog pathwayBAHCECI SULEYMAN·Filed 2008·Granted Jul 17, 2012·3 cites·32 claims
- 2276US7994172B2[1H-pyrazolo[3, 4-D]pyrimidin-4-yl]-piperidine or -piperazine compounds as serine-theoronine kinase modulators (P70s6k, Atk1 and Atk2) for the treatment of immunological, inflammatory and proliferative diseasesEXELIXIS INC·Filed 2005·Granted Aug 9, 2011·4 cites·22 claims
- 2375US12195475B2Compounds for the treatment of kinase-dependent disordersEXELIXIS INC·Filed 2023·Granted Jan 14, 2025·0 cites·12 claims
- 2475US10035790B2RORγ modulatorsBRISTOL MYERS SQUIBB CO·Filed 2013·Granted Jul 31, 2018·3 cites·13 claims
- 2575US2020331860A1C-Met Modulators and Methods of UseEXELIXIS INC·Filed 2020·Application pending·0 cites
- 2674US12264161B2Heterocyclic adenosine receptor antagonistsEXELIXIS INC·Filed 2023·Granted Apr 1, 2025·0 cites·20 claims
- 2773US11795201B2Brown fat-selective adipokinesUNIV MASSACHUSETTS·Filed 2018·Granted Oct 24, 2023·1 cites·8 claims
- 2873US8754092B2Inhibitors of the hedgehog pathwayBAHCECI SULEYMAN·Filed 2012·Granted Jun 17, 2014·1 cites·1 claims
- 2973US2025320265A1Brown fat-selective adipokinesUNIV MASSACHUSETTS·Filed 2025·Application pending·0 cites
- 3073US2025367848A1ChainsawNANJING CHERVON IND CO LTD·Filed 2025·Application pending·0 cites
- 3172US8889664B2Phosphatidylinositol 3-kinase inhibitors and methods of their useBAJJALIEH WILLIAM·Filed 2011·Granted Nov 18, 2014·3 cites·10 claims
- 3272US2024025919A1Aza-tetracyclic oxazepine compounds and uses thereofGENENTECH INC·Filed 2023·Application pending·0 cites
- 3372US2024150371A1Compounds for the Treatment of Kinase-Dependent DisordersEXELIXIS INC·Filed 2023·Application pending·0 cites
- 3470US2024043414A1Compounds for the Treatment of Kinase-Dependent DisordersEXELIXIS INC·Filed 2022·Application pending·0 cites
- 3568US8367667B2Pyrrole derivatives as pharmaceutical agentsEXELIXIS INC·Filed 2011·Granted Feb 5, 2013·1 cites·33 claims
- 3666US2014155396A1C-Met Modulators and Method of UseEXELIXIS INC·Filed 2013·Application pending·0 cites
- 3766US2014155378A9c-Met Modulators and Method of UseEXELIXIS INC·Filed 2013·Application pending·0 cites
- 3865US10835552B2Method for preparing linseed polysaccharide having antiviral activity and immunological activity, and use of the linseed polysaccharideUNIV JINAN·Filed 2016·Granted Nov 17, 2020·1 cites·5 claims
- 3964US2016185725A1c-Met Modulators and Method of UseEXELIXIS INC·Filed 2016·Application pending·0 cites
- 4063US2012184523A1C-Met Modulators and Method of UseBANNEN LYNNE CANNE·Filed 2012·Application pending·0 cites
- 4163US2025051284A1Compounds for the treatment of kinase-dependent disordersEXELIXIS INC·Filed 2022·Application pending·0 cites
- 4262US11673897B2Compounds for the treatment of kinase-dependent disordersEXELIXIS INC·Filed 2019·Granted Jun 13, 2023·0 cites·14 claims
- 4362US2015376133A1C-Met Modulators and Methods of UseEXELIXIS INC·Filed 2015·Application pending·0 cites
- 4460US2011077233A1C-Met Modulators and Method of UseEXELIXIS INC·Filed 2010·Application pending·0 cites
- 4558US2008187928A1Methods for enhancing exercise performanceSALK INST FOR BIOLOGICAL STUDI·Filed 2007·Application pending·0 cites
- 4657US12497367B2Processes for the preparation of a kinase inhibitorEXELIXIS INC·Filed 2021·Granted Dec 16, 2025·0 cites·25 claims
- 4757US2024425478A1Cyclopentylpyrazole cdk2 inhibitorsGENENTECH INC·Filed 2022·Application pending·0 cites
- 4856US8796294B2Inhibitors of the hedgehog pathwayBAHCECI SULEYMAN·Filed 2012·Granted Aug 5, 2014·0 cites·14 claims
- 4953US12503438B2Compounds for the treatment of kinase-dependent disordersEXELIXIS INC·Filed 2020·Granted Dec 23, 2025·0 cites·10 claims
- 5053US2014005238A1Methods for enhancing exercise performanceSALK INST FOR BIOLOGICAL STUDI·Filed 2013·Application pending·0 cites
Showing the top 50 of 71 patent records by PatentIndex Score.
Join the waitlist — get patent alerts
Get an alert when Yong Wang files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →